Concepedia

An EpCAM/CD3 bispecific antibody efficiently eliminates hepatocellular carcinoma cells with limited galectin-1 expression

Pengfei Zhang, Bizhi Shi, Huiping Gao, Hua Jiang, Juan Kong, Jin Yan, Xiaorong Pan, Kesang Li, Pengwei Zhang, Ming Yao,

Cancer Immunology Immunotherapy · 2013 · 47 citations · 33 references

DOIFull text

Open access

Concepts

References

33

Hepatocellular carcinoma

Josep M. Llovet, Andrew K. Burroughs, Jordi Bruix · The Lancet · 2003 · 3.6K citations

EpCAM-Positive Hepatocellular Carcinoma Cells Are Tumor-Initiating Cells With Stem/Progenitor Cell Features

Taro Yamashita, Junfang Ji, Anuradha Budhu et al. · Gastroenterology · 2008 · 1.1K citations · Full text

, , +12

Targeted Therapy With the T-Cell–Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free Survival

Max S. Topp, Peter Kufer, Nicola Gökbuget et al. · Journal of Clinical Oncology · 2011 · 913 citations · Full text

, , +16

CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway

Stephanie Ma, Terence K. Lee, BJ Zheng et al. · Oncogene · 2007 · 773 citations

, , +16

Nuclear signalling by tumour-associated antigen EpCAM

Dorothea Maetzel, Sabine Denzel, Brigitte Mack et al. · Nature Cell Biology · 2009 · 727 citations

, , +12